U.S Class(es): 006, 018, 044, 046, 051, 052
Class Status: Active
First Use: Sep-09-2015
First Use in Commerce: Sep-09-2015
| Name | TARO PHARMACEUTICALS U.S.A., INC. |
|---|---|
| Address | 3 Skyline Drive Hawthorne, NY 10532 United States |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Aug-17-2015 | NEW APPLICATION ENTERED | NWAPI | |
| Aug-18-2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Sep-16-2015 | TEAS AMENDMENT OF USE RECEIVED | EAAUI | |
| Sep-17-2015 | USE AMENDMENT FILED | IUAFS | |
| Sep-17-2015 | AMENDMENT TO USE PROCESSING COMPLETE | AUPCI | |
| Nov-27-2015 | ASSIGNED TO EXAMINER | DOCKD | |
| Dec-01-2015 | USE AMENDMENT ACCEPTED | IUAAP | |
| Dec-01-2015 | NON-FINAL ACTION WRITTEN | CNRTR | |
| Dec-01-2015 | NON-FINAL ACTION E-MAILED | GNRTF | |
| Dec-01-2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | GNRNO | |
| Dec-02-2015 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | AAUAE | |
| May-19-2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | TROAI | |
| May-19-2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE | CRFAI | |
| May-19-2016 | TEAS/EMAIL CORRESPONDENCE ENTERED | TEMEI | |
| May-19-2016 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
| Jun-01-2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
| Jun-21-2016 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Jun-21-2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
| Sep-06-2016 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
| Mar-06-2017 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | REAPI | |
| Mar-06-2017 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | ARAAI | |
| Sep-06-2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | REM1E | |
| Aug-25-2022 | TEAS SECTION 8 & 15 RECEIVED | E815I | |
| Mar-10-2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | APREA | |
| Mar-11-2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | C15AO | |
| Mar-11-2023 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | NA85E | |
| Sep-06-2025 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | REM2E | |
| Sep-24-2025 | TEAS SECTION 8 & 9 RECEIVED | E89RI |